Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic

Blood Transfus. 2022 May;20(3):263-264. doi: 10.2450/2021.0196-21. Epub 2021 Sep 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Viral
  • Asymptomatic Infections / epidemiology
  • Blood Donors
  • COVID-19* / diagnosis
  • COVID-19* / epidemiology
  • Humans
  • Italy / epidemiology
  • Pandemics
  • Prevalence
  • SARS-CoV-2*

Substances

  • Antibodies, Viral